Deeply engaged in the CDMO field more than 10 years, Tianshu has four major technology platforms, including chiral drug synthesis and analysis technology, bio-enzyme engineering technology, continuous flow engineering technology and photochemical technology, a rich bio-enzyme library, and multiple sets of microchannel and micro-packed bed equipment. It excels in various chemical synthesis reaction types such as coupling, rearrangement, Grignard and ultra-low temperature.

We are equipped with reactors of various specifications from 50L to 5000L, ranging from pilot to industrialization, to meet customers' product needs with different outputs from kilograms to tons.

The team has sufficient professional and technical talents in various disciplines such as chemistry, chemical engineering and pharmacy, rich project experience and excellent industry reputation, which can quickly accomplish project launch and timely delivery.

With extensive registration experience and a comprehensive quality management system, we meet product regulatory registration requirements and cGMP production conditions. We have successfully passed many audits by competent authorities and customers in the past three years.